Last reviewed · How we verify
NCT02378779: GETUP
Consultations Reason for Genital, Urinary or Psychological Humans in General Practice
NA trial testing Questionary SF12 and PEDT (Premature Ejaculation Diagnostic Tool) in Premature Ejaculation in 132 participants. Terminated before completion.
22 April 2018
Quick facts
| Lead sponsor | University Hospital, Brest |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 132 |
| Start date | 22 April 2016 |
| Primary completion | 22 April 2018 |
| Estimated completion | 22 April 2018 |
| Sites | 23 locations across France |
Drugs / interventions tested
- Questionary SF12 and PEDT (Premature Ejaculation Diagnostic Tool)
- Total attention
- Humour
- Take the drama out
- Question about premature ejaculation
- Symptoms of premature ejaculation
- Help to verbalize
Conditions studied
- Premature Ejaculation — all drugs for Premature Ejaculation →
Sponsor
University Hospital, Brest
Who can join
Adults 18 to 80, male only, with Premature Ejaculation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Many male patients complain about their ejaculation: 21-30% of men aged between 18 and 59 have admitted suffering from a decrease in, or loss of control of, their ejaculation. The quality of life of patients and their partners is impaired compared to men not suffering from premature ejaculation. Economically, the impact of the disease are significant. In the year preceding the detection of premature ejaculation patients visit twice their physician. The majority of men interviewed anonymously, in their General Practitioner's ( GP's) waiting room, considered it important to talk with their GP about their sexual concerns. Almost half of them preferred that their GP initiate any discussions about sexuality. More than two thirds of the respondents would have liked their GP to signal his or her open-mindedness by directly addressing sexual topics during the consultation. In 2008 a qualitative study brought to the fore the strategies used by GPs to initiate the discussion on premature ejaculation . GPs who mentioned premature ejaculation with their patient described three attitude-related strategies and three investigative strategies.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Premature ejaculation in primary care: communication strategies versus usual care for male patients consulting for a sexual, urogenital or psychological reason - GET UP: study protocol for a cluster randomised controlled trial.
Barais M, Vaillant Roussel H, Costa D, Derriennic J, et al · · 2018 · cited 3× · PMID 30419940 · DOI 10.1186/s13063-018-2947-2 -
Talking about premature ejaculation in primary care: the GET UP cluster randomised controlled trial.
Barais M, Costa M, Montalvo C, Rannou V, et al · · 2022 · cited 1× · PMID 34862162 · DOI 10.3399/bjgpo.2021.0168
Verify or expand the search:
- PubMed search for NCT02378779
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Premature Ejaculation
Currently open trials in the same condition.
- NCT07442396 — The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation · NA · recruiting
- NCT07434271 — Study to Evaluate the Potential Effects of KH-001 on Intravaginal Ejaculatory Latency Time (IELT), Patient-Reported Outc · Phase 2 · recruiting
- NCT06570135 — Brain Activity During Sexual Behavior in Patients With Primary Premature Ejaculation a Clinical Trial · NA · recruiting
- NCT06851598 — Safety and Efficacy of Botulinum Toxin-A Injection Into Ischiocavernosus Muscle for Premature Ejaculation · Phase 2, PHASE3 · active not recruiting
- NCT06605469 — Ejaculatory and Orgasmic Dysfunction Registry · recruiting
Other University Hospital, Brest trials
Trials by the same sponsor.
- NCT07526688 — Aerobic Physical Activity and Orofacial Myofascial Pain · NA · not yet recruiting
- NCT07487155 — Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Dis · NA · not yet recruiting
- NCT07417605 — Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiatio · not yet recruiting
- NCT07302074 — Understanding of Rare Inflammatory Arthritis in Comparison to Classical Inflammatory Arthritis : Tissular Observations a · NA · recruiting
- NCT06441773 — Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated W · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02378779 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Brest
- Last refreshed: 19 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02378779.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing